Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:1217-1222
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Obaidi, M. K.
Right arrow Articles by Noble, M. I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Obaidi, M. K.
Right arrow Articles by Noble, M. I. M.

Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes

Mohamed K. Al-Obaidi, MD, MRCPa, Peter J. Stubbs, MD, MRCPa, Paul Collinson*, Ronan Conroy, BMus{dagger}, Ian Graham, FRCPI{dagger} and Mark I. M. Noble, DSc, MDa

a National Heart and Lung Institute, Cardiology Department, Charing Cross Campus, Imperial College School of Medicine, London, United Kingdom
* Department of Chemical Pathology, Mayday University Hospital, London, United Kingdom
{dagger} Department of Epidemiology, Royal College of Surgeons, Dublin, Ireland



View larger version (29K):

[in a new window]
 
Figure 1 Admission cTnT levels by quintiles of admission homocysteine in patients with (a) MI, (b) UAP, and (c) all ACS patients.

 


View larger version (25K):

[in a new window]
 
Figure 2 Peak cTnT levels by quintiles of admission homocysteine in patients with (a) MI, (b) UAP, and (c) all ACS patients.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement